Trials / Completed
CompletedNCT01832194
Use of Botox to Treat Scrotal Pain
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Mount Sinai Hospital, Canada · Academic / Other
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
There are no previous reports on the use of Onabotulinum Toxin A to treat men with scrotal pain that we found published. We propose a pilot study to use Botox to block the testicular nerves on a group of 15 men with chronic scrotal pain who have failed the standard medical therapy. The men must have had temporary relief from a testicular cord block using marcaine. Before and 1 month, 3 months and 6 months after the Onabotulinum Toxin A injection, the men would be asked to fill in visual analog scales for pain, a quality of life assessment, a depression index (MDI) and Chronic Epididymitis Symptom Index (CESI). They will also be subject to sensory testing of the scrotum before, after 1 month, 3 moths and 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botox |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2013-04-15
- Last updated
- 2014-09-01
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01832194. Inclusion in this directory is not an endorsement.